(UPDATED July 25, 2013) — A major observational study in ankylosing spondylitis (AS) published online July 1 in Arthritis & Rheumatism revealed that tumor necrosis factor (TNF) inhibitors ...
If you are one of the approximately 1.5 percent of Americans who have been diagnosed with axial spondyloarthritis (axSpA)—a chronic inflammatory rheumatic disease that can cause pain, stiffness, and ...
Bimekizumab demonstrated safety and efficacy at 2 years among patients with nonradiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS). Bimekizumab is currently FDA approved ...
Across 2024, top immunology news focused on ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis, highlighting studies on gut bacteria, radiographic progression, socioeconomic factors ...
Ankylosing Spondylitis (AS) is the leading chronic progressive inflammatory rheumatic disease that involves the sacroiliac joints (SIJs) and the spinal column but is often difficult to recognize in ...
For decades, ankylosing spondylitis was considered a man’s disease, but new research reveals something shocking: ankylosing spondylitis hits women differently and nearly as frequently as men, yet ...
Patients with ankylosing spondylitis/axial spondyloarthritis (AS/axSpA) have their disease onset at young age, which increases the lifetime impact of their disease-associated reduced vitality and ...
Hosted on MSN
Ankylosing Spondylitis: How to Deal With Fatigue
Ankylosing spondylitis (AS), a type of arthritis that affects joints, tendons, and ligaments in the lower back and the base of the spine, can make you feel as if your energy has been zapped. It’s a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results